Orchidia Pharmaceutical Industries (Orchidia) has more than 25 years’ experience in the pharmaceutical market. Orchidia is well-known for its reputation in the MEA region, and mutual trust of patients and ophthalmology physicians in our safe and high-quality products as well as our responsiveness to customers.
It all began in 1993, Orchidia Promotions was established, as a pharmaceutical service provider in the field of marketing and support activities like DRA, recruitment, training, etc. Orchidia Promotions
entered the pharmaceutical sector in Egypt with the aim of providing promotional services to multinational pharmaceutical companies, this was the gateway through which Orchidia gained its vast experiences.
Orchidia Promotions served as the local agent for many well-known multinational pharmaceutical companies from 1993 till 2002. During this period, Orchidia Promotions was responsible for launching, marketing and distribution of a wide range of eye care and general medicine products in Egypt. At that time; both Dr. Ossama Abbas (current Chairman & CEO of Orchidia) with the late Dr. Salwa Eid acted as marketing and distribution consultants. In 2003 Orchidia Promotions changed its name to be Orchidia Pharma due to a change in company activities.
Orchidia Pharma used its accumulated expertise to shift from a service provider to a local manufacturer for affordable high-quality eye care products. In 2005, Dr. Ossama Abbas decided to build our own manufacturing facility ''Orchidia Pharmaceutical Industries'' in Al-Obour city industrial area. Orchidia’s manufacturing site is the 1st plant in Egypt to introduce the Blow-Fill-Seal technology for producing ophthalmic solutions. This technology ensures precision and product sterility; as each plastic bottle is formed, filled, and sealed in a totally sterile automated process without any human intervention. Since then, Orchidia has catapulted into a leading position in the Egyptian market, with an ever expanding regional presence. We are currently ranked second in terms of total sales value in the ophthalmic market among 51 operating competitors. We have lead growth in the market in the past decade, nearly doubling the rate of market growth.